They're pushing for more funding to find effective treatments. Researchers are finally starting to make headway but have a ...
A Lancet study shows promising results for an annual HIV prevention injection, lenacapavir. In Stage 1 trials, 40 HIV-negative participants had no significant side effects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results